Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

High-throughput cell-based assays for identifying antagonists of multiple smoking-associated human nicotinic acetylcholine receptor subtypes

SLAS DISCOVERY(2022)10.1016/j.slasd.2021.10.001Source: DataRank Database

High-throughput cell-based assays for identifying antagonists of multiple smoking-associated human nicotinic acetylcholine receptor subtypes is a research paper published in SLAS DISCOVERY (2022). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: goldTopics (27)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

J. Brek Eaton,Nanyun Tang ORCID,Joachim L. Petit ORCID,Nathalie Meurice ORCID,Hongwei Yin ORCID

Live enrichment

PubMed:35058178 PMC:PMC8816891

National Institutes of Health

Grant: R21DA032483

National Institutes of Health

Grant: R21DA036059

National Institutes of Health

Grant: R01DA042749

National Institutes of Health

Grant: 5R21DA036059-02

High-Throughput Assay Development for Non-Nicotine Tobacco Components

National Institutes of Health

Grant: 5R01DA042749-04

Relevance of α-Conotoxin MII Sensitive Nicotinic Receptor Subtypes to Nicotine Addiction

National Institutes of Health

Grant: 1R21DA032483-01

HTS Assay Development for alpha6/3beta2beta3 Subtype Nicotinic Receptors

Barrow Neurological Foundation

goldLicense: cc-by

publisherhttp://slas-discovery.org/article/S2472555221000010/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2472555221000010?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2472555221000010?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8816891

Europe_PMChttps://europepmc.org/articles/PMC8816891

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

HumansNicotineReceptors, NicotinicNicotinic AgonistsSmokingTobacco Smoke PollutionHigh-Throughput Screening AssaysElectronic Nicotine Delivery Systems

Keywords

Nicotinic acetylcholine receptorCell-based ScreeningMembrane Potential AssaysMedicine (General)NicotineSmokingElectronic Nicotine Delivery SystemsReceptors, NicotinicArticleHigh-Throughput Screening AssaysR5-920HumansTobacco Smoke PollutionNicotinic AgonistsTP248.13-248.65Biotechnology

Sustainable Development Goals

SDG 3: 3. Good health

High-throughput cell-based assays for identifying antagonists of multiple smoking-associated human nicotinic acetylcholine receptor subtypes

FAIR Checklist

Authors (7)

Funding (7 grants)

Open Access

Topics

Annotations (Europe PMC)